0.1 semaglutide Blockbuster GLP-1 Diabetes and Weight Loss Drugs Fails in Alzheimer's Trial Semaglutide and tirzepatide treatment leads

Novo Nordisk has announced a $1.05B investment to expand its manufacturing site in Montes Claros, Brazil, one of the largest pharma investments in the countrys history

Contact us for personalized formulations today.

As GLP-1 weight-loss drug costs surge, most Connecticut employers cover them but impose conditions like prior authorization and lifestyle requirements to manage expenses, a strategy the state employee plan has used to slow spending growth.

OZEMPIC (semaglutide) injection can be accessed on request

Food and Drug Administration (FDA) approved Wegovy (the brand name for once-weekly Semaglutide 2.4 mg injection) for chronic weight management